Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation

Blood

Volumn 88, Issue 7, 1996, Pages 2794-2800

  Bensinger, William I ^a,b   Clift, Reginald ^a   Martin, Paul ^a   Appelbaum, Frederick R ^a   Demirer, Taner ^a   Gooley, Ted ^a   Lilleby, Kathy ^a   Rowley, Scott ^a   Sanders, Jean ^a   Storb, Rainer ^a   Buckner, C Dean ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOTRANSPLANTATION; ARTICLE; CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HLA MATCHING; HODGKIN DISEASE; HUMAN; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 10144244635     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2794.bloodjournal8872794     Document Type: Article

References (26)

1. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton JE, Green MD, Souza L, Fox RM: Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891, 1989
2. Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clarke E, Clift R, Hansen J, Shields T, Storb R, Weaver C, Weiden P, Buckner CD: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993
3. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R, Buckner CD: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825, 1994
4. Namdemanee A, Sniecinzki IJ, Schmidt CA, Dagis AC, O'Donnell M, Snyder DS, Parker PM, Stein AS, Smith EP, Arturo M, Stepan DE, Somlo G, Margolin KA, Woo SD, Niland JC, Forman SJ: High-Dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with hodgkin's disease and non-hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilzed peripheral-blood stem cells. J Clin Oncol 12:2176, 1995
5. Bolwell BJ, Fishman EK, Andresen S, Lichtin A, Yanssens T, Burwell R, Baucco P, Green R: G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: Parameters afecting bone marrow engraftment. Bone Marrow Transplant 12:609, 1993
6. Weaver GH, Buckner CD, Longin K, Appelbaum FR, Rowley S, Lilleby K, Miser J, Storb R, Hansen JA, Bensinger W: Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 82:1981, 1993
7. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, Williams B, Storb R, Thomas ED, Buckner CD: The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81:1883, 1993
8. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
9. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Löffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (G-CSF). Blood 85:1666, 1995
10. Körbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
11. Thomas ED: Allogeneic marrow transplantation using matched sibling donors. Transplant Proc 6:115, 1974
12. Nemunaitis J, Buckner CD, Appelbaum FR, Higano CS, Mori M, Bianco J, Epstein C, Lipani J, Hansen J, Storb R, Thomas ED, Singer JW: Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation. Blood 77:2065, 1991
13. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooiey T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner CD: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547, 1995
14. Kirk JA, VanDavantar DR, Biberman J, Bryant EM: Y chromosome loss in chronic myeloid leukemia detected in both normal and malignant cells by interphase fluorescence in situ hybridization. Genes Chromosomes Cancer 11:141, 1994
15. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC: Analysis Of the VNTR locus DIS80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 48:137, 1991
16. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED: Consensus conference on acute GVHD grading. Bone Marrow Transplant 15:825, 1995
17. Sullivan KM, Witherspoon RP, Storb R, Anasetti C, Appelbaum FR, Bigelow C, Clark J, Doney K, Hill R, Loughran T, Matthews DD, Nims J, Petersen F, Sanders J, Schüning F, Shields A, Strom S, Thomas ED: Chronic graft-versus-host disease: Recent advances in diagnosis and treatment, in Gale RP, Champlin R (eds): Bone Marrow Transplantation: Current Controversies. UCLA Symposia on Molecular and Cellular Biology, New Series, vol 91. New York, NY, Liss, 1989, p 511
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
19. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, Meyers JD, Bowden RA: Efficacy and safety of fluconazole for fungal infections after marrow transplant - A prospective, randomized, double-blind study. J Infect Dis 171:1545, 1995
20. Kernan NA, Collins NM, Juliano L, Cartagenia T, Dupont B, O'Reilly RJ: Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-versus-host disease. Blood 68:770, 1986
21. Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK: Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood 83:3090, 1994
22. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JLM: Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft versus host disease. Blood 86:4422, 1995
23. Talmadge JE, Reed EC, Kessinger A, Kuszynski CA, Perry GA, Gordy CL, Mills KC, Thomas ML, Pirruccello SJ, Letheby BA, Arneson MA, Jackson JD: Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 17:101, 1996
24. + cell from haploidentical parental donors for relapsed acute leukemia in children. Blood 86:1149, 1995 (abstr, suppl 1)
25. + Peripheral Blood Stem Cells (PBSC) in older patients with advanced hematologic malignancy. Blood 86:1545, 1995 (abstr, suppl 1)
26. Sullivan KM, Storb R, Buckner CD, Fefer A, Fisher L, Weiden PL, Witherspoon RP, Appelbaum FR, Banaji M, Hansen J, Martin P, Sanders JE, Singer J, Thomas ED: Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. N Engl J Med 320:828, 1989